These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 29787808
1. Lipoxin A4 and its analog suppress hepatocarcinoma cell epithelial-mesenchymal transition, migration and metastasis via regulating integrin-linked kinase axis. Xu F, Zhou X, Hao J, Dai H, Zhang J, He Y, Hao H. Prostaglandins Other Lipid Mediat; 2018 Jul; 137():9-19. PubMed ID: 29787808 [Abstract] [Full Text] [Related]
2. BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway. Lin L, Luo X, Wang L, Xu F, He Y, Wang Q, Yuan C, Xu J, Yan L, Hao H. Int Immunopharmacol; 2020 Aug; 85():106625. PubMed ID: 32485356 [Abstract] [Full Text] [Related]
3. Lipoxin A4 and its analog suppress hepatocellular carcinoma via remodeling tumor microenvironment. Hao H, Liu M, Wu P, Cai L, Tang K, Yi P, Li Y, Chen Y, Ye D. Cancer Lett; 2011 Oct 01; 309(1):85-94. PubMed ID: 21683517 [Abstract] [Full Text] [Related]
4. Lipoxin A4 Suppresses Estrogen-Induced Epithelial-Mesenchymal Transition via ALXR-Dependent Manner in Endometriosis. Wu RF, Huang ZX, Ran J, Dai SJ, Lin DC, Ng TW, Chen QX, Chen QH. Reprod Sci; 2018 Apr 01; 25(4):566-578. PubMed ID: 28691579 [Abstract] [Full Text] [Related]
5. Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer. Zong L, Chen K, Jiang Z, Chen X, Sun L, Ma J, Zhou C, Xu Q, Duan W, Han L, Lei J, Li X, Ma Q, Wang Z. J Exp Clin Cancer Res; 2017 Dec 11; 36(1):181. PubMed ID: 29228980 [Abstract] [Full Text] [Related]
6. Downregulation of integrin-linked kinase inhibits epithelial-to-mesenchymal transition and metastasis in bladder cancer cells. Zhu J, Pan X, Zhang Z, Gao J, Zhang L, Chen J. Cell Signal; 2012 Jun 11; 24(6):1323-32. PubMed ID: 22570869 [Abstract] [Full Text] [Related]
7. Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways. Zhuang X, Lv M, Zhong Z, Zhang L, Jiang R, Chen J. J Exp Clin Cancer Res; 2016 Aug 30; 35(1):130. PubMed ID: 27576342 [Abstract] [Full Text] [Related]
8. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells. Yao X, Li D, Xiong DM, Li L, Jiang R, Chen JX. Cell Tissue Res; 2013 Sep 30; 353(3):409-23. PubMed ID: 23703635 [Abstract] [Full Text] [Related]
9. Twist induces epithelial-mesenchymal transition and cell motility in breast cancer via ITGB1-FAK/ILK signaling axis and its associated downstream network. Yang J, Hou Y, Zhou M, Wen S, Zhou J, Xu L, Tang X, Du YE, Hu P, Liu M. Int J Biochem Cell Biol; 2016 Feb 30; 71():62-71. PubMed ID: 26693891 [Abstract] [Full Text] [Related]
10. Lipoxin A4 interferes with embryo implantation via suppression of epithelial-mesenchymal transition. Xu Z, Zhao S, Zhou T, Liao T, Huang X, Xiang H, Zhang Q, Huang Y, Lin F, Ye D, Huang Y. Am J Reprod Immunol; 2019 May 30; 81(5):e13107. PubMed ID: 30811719 [Abstract] [Full Text] [Related]
11. Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition. Xing Y, Qi J, Deng S, Wang C, Zhang L, Chen J. Exp Cell Res; 2013 Aug 01; 319(13):2058-2072. PubMed ID: 23707970 [Abstract] [Full Text] [Related]
12. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. Fuchs BC, Fujii T, Dorfman JD, Goodwin JM, Zhu AX, Lanuti M, Tanabe KK. Cancer Res; 2008 Apr 01; 68(7):2391-9. PubMed ID: 18381447 [Abstract] [Full Text] [Related]
13. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway. Xiong D, Liou Y, Shu J, Li D, Zhang L, Chen J. Exp Mol Pathol; 2014 Jun 01; 96(3):411-21. PubMed ID: 24768914 [Abstract] [Full Text] [Related]
14. Overexpression of integrin-linked kinase (ILK) promotes migration and invasion of colorectal cancer cells by inducing epithelial-mesenchymal transition via NF-κB signaling. Yan Z, Yin H, Wang R, Wu D, Sun W, Liu B, Su Q. Acta Histochem; 2014 Apr 01; 116(3):527-33. PubMed ID: 24360977 [Abstract] [Full Text] [Related]
15. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway. Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY. Liver Int; 2015 Apr 01; 35(4):1416-29. PubMed ID: 25066210 [Abstract] [Full Text] [Related]
16. Overexpression of integrin-linked kinase correlates with malignant phenotype in non-small cell lung cancer and promotes lung cancer cell invasion and migration via regulating epithelial-mesenchymal transition (EMT)-related genes. Chen D, Zhang Y, Zhang X, Li J, Han B, Liu S, Wang L, Ling Y, Mao S, Wang X. Acta Histochem; 2013 Mar 01; 115(2):128-36. PubMed ID: 22683084 [Abstract] [Full Text] [Related]
17. Integrin-linked kinase overexpression promotes epithelial-mesenchymal transition via nuclear factor-κB signaling in colorectal cancer cells. Shen H, Ma JL, Zhang Y, Deng GL, Qu YL, Wu XL, He JX, Zhang S, Zeng S. World J Gastroenterol; 2016 Apr 21; 22(15):3969-77. PubMed ID: 27099440 [Abstract] [Full Text] [Related]
18. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT). Serrano I, McDonald PC, Lock FE, Dedhar S. Oncogene; 2013 Jan 03; 32(1):50-60. PubMed ID: 22310280 [Abstract] [Full Text] [Related]
19. A novel HIF-1α-integrin-linked kinase regulatory loop that facilitates hypoxia-induced HIF-1α expression and epithelial-mesenchymal transition in cancer cells. Chou CC, Chuang HC, Salunke SB, Kulp SK, Chen CS. Oncotarget; 2015 Apr 10; 6(10):8271-85. PubMed ID: 25821081 [Abstract] [Full Text] [Related]
20. Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells. Dong J, Zhai B, Sun W, Hu F, Cheng H, Xu J. PLoS One; 2017 Apr 10; 12(9):e0185088. PubMed ID: 28934275 [Abstract] [Full Text] [Related] Page: [Next] [New Search]